[Federal Register: November 10, 2004 (Volume 69, Number 217)]
[Notices]
[Page 65229]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10no04-184]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated May 21, 2004, and published in the Federal Register
on June 3, 2004, (69 FR 31411), American Radiolabeled Chemicals, Inc.,
101 Arc Drive, St. Louis, Missouri 63146, made application by renewal
to the Drug Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)........... I
Dimethyltryptamine (7435).................. I
Dihydromorphine (9145)..................... I
Cocaine (9041)............................. II
Codeine (9050)............................. II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Ecgonine (9180)............................ II
Meperidine (9230).......................... II
Metazocine (9240).......................... II
Morphine (9300)............................ II
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to manufacture in bulk, small quantities of the
listed controlled substances as radiolabeled compounds.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
American Radiolabeled Chemicals, Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated American Radiolabeled Chemicals,
Inc. to ensure that the company's registration is consistent with the
public interest. The investigation has included inspection and testing
of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33, the above named company is
granted registration as a bulk manufacturer of the basic classes of
controlled substances listed.
Dated: November 1, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 04-25103 Filed 11-9-04; 8:45 am]
BILLING CODE 4410-09-P